We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
LifeEDIT is a discovery-phase pharmaceutical development company that has identified the world’s largest and most diverse set of novel CRISPR gene editing systems. We are focused on the development and commercialization of human therapeutics using our unique CRISPR technologies. In a short time LifeEDIT has already developed the world’s largest and most diverse collection of CRISPR based nucleic acid editing proteins with multiple unique PAM recognition elements. These are being deployed to develop novel therapeutics in Immuno/oncology, Neurodegenerative Diseases and select hematopoietic disorders.